· Periodic Report
Q3 operating profit KRW 2.8 billion, down 77.4% from a year earlier; net loss KRW 7.0 billion
United Pharm sold KRW 68.1 billion worth in Q3 and earned KRW 2.8 billion from its main business, down 77.4% from a year earlier and 78.8% from the previous quarter.